Evidence map›Paper›PMID 26979508›Full record

SynthesisHerz2016

Colchicine in addition to conventional therapy for pericarditis recurrence : An update meta-analysis.

Y-L Li, S-B Qiao, J-Y Wang, Y-M Chen, J Luo, H-F Zhang

Abstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Herz, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Y-L LiHealth Division of Guard Bureau, General staff Department of Chinese PLA, Beijing, China.
S-B QiaoDepartment of Cardiology, The People's Hospital of Rizhao, Rizhao, Shandong, China.
J-Y WangDepartment of Cardiovascular Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Y-M ChenDepartment of Pediatrics, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
J LuoHealth Division of Guard Bureau, General staff Department of Chinese PLA, Beijing, China.
H-F ZhangHealth Division of Guard Bureau, General staff Department of Chinese PLA, Beijing, China. zhanghaifeng201406@126.com.
Beijing Chao-Yang Hospital · CNPeople’s Hospital of Rizhao · CNSecond People's Hospital of Yunnan Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRandomized controlled trials (RCTs) have investigated the use of colchicine and conventional therapy for reducing the recurrence of pericarditis in patients with acute pericarditis or post-pericardiotomy syndrome. However, the benefits of these treatments are variable.

methodsStudies were retrieved from PubMed, the Cochrane Library, and the EMBASE database.

resultsWe identified nine RCTs with 1832 patients and a mean follow-up of 13.1 months. Overall, colchicine therapy significantly decreased the risk of pericarditis recurrence (odds ratio, OR 0.42; 95 % confidence interval, CI 0.33-0.52; P < 0.001; I

conclusionColchicine significantly decreases the rate of pericarditis recurrence, regardless of prednisone use and the cause of pericarditis. Larger studies are needed to confirm this effect.

Indexed as

AgedAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalColchicineDrug CombinationsFemaleHumansMaleMiddle AgedPericarditisPrednisonePrevalenceRecurrenceRisk FactorsTreatment OutcomeAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalColchicineDrug CombinationsPrednisoneAdverse eventPost-pericardiotomy syndromePrednisoneRandomized controlled trialsRecurrence

Identifiers

PMID26979508
OpenAlexW2305836146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.